AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-88243330/low-dose-vivelle-dot.html" title="Facts and information about Low-dose Vivelle-Dot (estradiol transdermal system) approved for postmenopausal osteoporosis prevention.(Brief Article)">Low-dose Vivelle-Dot (estradiol transdermal system) approved for postmenopausal osteoporosis prevention.(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Women's Health Weekly are available.
Frequently asked questions about RSS feeds
Low-dose Vivelle-Dot (estradiol transdermal system) approved for postmenopausal osteoporosis prevention.(Brief Article)
2002 JUL 11 - (NewsRx.com & NewsRx.net) -- About the size of a dime, Vivelle-Dot's newest dosage - according to the company, the smallest estrogen replacement patch in the world - is now approved in the 0.025 mg/day dosage strength, providing among the lowest effective estrogen replacement therapy (ERT) dosage strengths available in the U.S. for the prevention of postmenopausal osteoporosis.
Vivelle-Dot's original 4-dosage strengths (0.0375, 0.05, 0.075 and 0.1 mg/day), available for the treatment of ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Vivelle-Dot(R) (estradiol transdermal system) Now Approved in New, Low Dose for...
- Press release article from: PR Newswire May 20, 2002 700+ words
...fight against postmenopausal osteoporosis. Vivelle-Dot is now approved...prevention of postmenopausal osteoporosis. This new...Vivelle-Dot's original...prevention of postmenopausal osteoporosis. Vivelle-Dot 0.025 mg...
- ESTRACE(R) ESTROGEN REPLACEMENT THERAPY CLEARED BY FDA FOR PREVENTION OF...
- Press release article from: PR Newswire September 21, 1992 700+ words
...CLEARED BY FDA FOR PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS Studies Show ESTRACE Increases...indication -- the prevention of postmenopausal osteoporosis. ESTRACE has been marketed...effective in the prevention of postmenopausal osteoporosis -- the loss of bone mass that...
- NEW TREATMENT CHOICE OFFERS HOPE FOR WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
- Press release article from: PR Newswire December 6, 1995 700+ words
...millions of American women with postmenopausal osteoporosis have new treatment choices for...Nasal Spray, a unique form of postmenopausal osteoporosis therapy, is available in pharmacies...American women. "The fact that postmenopausal osteoporosis patients and their health care...
- NEW NASAL SPRAY TREATMENT FOR POSTMENOPAUSAL OSTEOPOROSIS
- Press release article from: PR Newswire August 18, 1995 700+ words
...salmon) for the treatment of postmenopausal osteoporosis. Widening the therapeutic options...considered first line therapy for postmenopausal osteoporosis approximately 30-50 percent...women are at risk of developing postmenopausal osteoporosis. Currently, in addition to...
- FDA Approves First IV Treatment for Postmenopausal Osteoporosis - Boniva(R)...
- Press release article from: PR Newswire January 6, 2006 700+ words
...medication for the treatment of postmenopausal osteoporosis, Roche and GlaxoSmithKline...medication for the treatment of postmenopausal osteoporosis, is a member of the bisphosphonate...trial in 1,358 women with postmenopausal osteoporosis. Boniva Injection will be available...
- Ligand Announces Approval in Europe of CONBRIZA[TM] for Treatment of...
- Press release article from: Business Wire April 27, 2009 700+ words
...treatment of postmenopausal osteoporosis in women at...prevention of postmenopausal osteoporosis, and in July...treatment of postmenopausal osteoporosis. Wyeth has...
- Weekly doses of ibandronate improve postmenopausal osteoporosis.
- Newspaper article from: Clinical Trials Week December 1, 2003 700+ words
...doses of ibandronate improve postmenopausal osteoporosis. According to recent research...daily bisphosphonate regimens in postmenopausal osteoporosis is currently suboptimal. Less...than or equal to 3 yr) with postmenopausal osteoporosis [lumbar spine (L1-L4) bone...
- Once-yearly Reclast(R) Significantly Reduced Bone Fractures in Women with...
- Press release article from: PR Newswire May 2, 2007 700+ words
...over three years in women with postmenopausal osteoporosis. This study, published today...weekly or monthly doses for postmenopausal osteoporosis, Reclast is given as a once...FDA) for the treatment of postmenopausal osteoporosis. "Unfortunately, many patients...